Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blopress (candesartan cilexetil) specified drug-use survey in hypertensive patients with metabolic syndrome risk factors
jRCT1080222516
- Sponsor
- Takeda
- Start
- Jun 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of candesartan cilexetil in hypertension (HTN) and cardiometabolic risk (CMR), sponsored by Takeda.
02
Drugs
candesartan cilexetil
03
Conditions
hypertension (HTN)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on jRCT1080222516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222516.